Загрузка...
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
BACKGROUND: The incidence of gout rises with increasing age. Management of elderly (≥65 years) gout patients can be challenging due to high rates of comorbidities, such as renal impairment and cardiovascular disease, and concomitant medication use. However, there is little data specifically addressi...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368715/ https://ncbi.nlm.nih.gov/pubmed/22436129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2318-12-11 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|